GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Bio-reference Laboratories, Inc. (BRLI) [hlAlert]

Rating:
Perform BRLI
up 448.02 %

Bio-reference Laboratories, Inc. (BRLI) rated Perform with price target $25 by Oppenheimer

Posted on: Friday,  Jan 9, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Bio-reference Laboratories, Inc. (NASDAQ: BRLI) on 01/09/2009. Previously Oppenheimer rated Outperform Bio-reference Laboratories, Inc. (NASDAQ: BRLI) on 05/29/2008.,
when the stock price was $6.38. Since then, Bio-reference Laboratories, Inc. has gained 448.02% as of 08/19/2015's recent price of $34.95.
If you would have followed the previous Oppenheimer's recommendation on BRLI, you would have gained 448.02% of your investment in 2638 days.

Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing clinical laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states. Bio-Reference offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radioimmuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis. The Company operates two clinical laboratories, one in Elmwood Park, New Jersey and one in Valley Cottage, New York, and an andrology laboratory in New York City, a cytogenetics testing laboratory located in Milford, Massachusetts, a pathology laboratory in Poughkeepsie, New York, a pathology laboratory in Clarksburg, Maryland and a genetics laboratory in Gaithersburg, Maryland.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2009 8:25 AM Buy
None
6.17 6.25
as of 12/31/2009
1 Week up  21.52 %
1 Month up  42.19 %
3 Months up  35.58 %
1 YTD up  77.81 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2008 8:25 AM Buy
None
6.38 7.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy